Farmacovigilancia de vacunas y su aplicación en Chile

Farmacovigilancia de vacunas y su aplicación en Chile

Resumen: La inmunización se encuentra entre las intervenciones en salud pública más exitosas y costo efectivas de todas las épocas, siendo su beneficio tan importante como su seguridad.Las vacunas, como cualquier otro medicamento, pueden generar eventos adversos, los que deben ser monitorizados perm...

Full description

Bibliographic Details
Main Authors:	Adiela Saldaña, María Rodríguez, Juan Roldán, Carmen Lobos, Cecilia González, Marcela Avendaño, Rodolfo Villena, Marcela González, Rodrigo Vásquez de Kartzow, Nahum Vergara
Format:	Article
Language:	English
Published:	Elsevier 2020-05-01
Series:	Revista Médica Clínica Las Condes
Subjects:	Vaccine pharmacovigilance vaccine safety adverse event following immunization (AEFI)
Online Access:	http://www.sciencedirect.com/science/article/pii/S0716864020300390

Similar Items

Using Population-Based Structures to Actively Monitor AEFIs during a Mass Immunization Campaign—A Case of Measles–Rubella and Polio Vaccines
by: Dan Kajungu, et al.
Published: (2021-11-01)

Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
by: Cristina Scavone, et al.
Published: (2018-09-01)

Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community—Spain (2008–2018)
by: Cecilia M. Egoavil, et al.
Published: (2020-03-01)

Vaccine Safety International Monitoring
by: M. A. Darmostukova, et al.
Published: (2019-03-01)

Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
by: Xuejiao Pan, et al.
Published: (2021-10-01)

Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia
by: C.-M. Baxter, et al.
Published: (2018-08-01)

Non-specific effects of vaccinations in high-income settings: How to address the issue?
by: Alberto Donzelli, et al.
Published: (2018-12-01)

Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study
by: Alessia Zinzi, et al.
Published: (2023-02-01)

Safety of COVID-19 vaccines
by: B. K. Romanov
Published: (2022-12-01)

A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study
by: Mohamed Serhan, et al.
Published: (2024-12-01)

Surveillance on the adverse events following immunization in Dazu District of Chongqing， 2016‒2020
by: WANG Qian, et al.
Published: (2022-04-01)

Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020
by: Yu Hu, et al.
Published: (2021-12-01)

Adverse Events Following Immunization with DTP Vaccine in Infants and Children in Kermanshah City: A Cohort Study
by: M Karami, et al.
Published: (2006-02-01)

Real-Life Safety Profile of the 9-Valent HPV Vaccine Based on Data from the Puglia Region of Southern Italy
by: Antonio Di Lorenzo, et al.
Published: (2022-03-01)

Safety Profile of Recommended Vaccinations in Adolescents: Data from Surveillance of Adverse Events Following Immunization in Puglia (Italy), 2016–2020
by: Antonio Di Lorenzo, et al.
Published: (2021-11-01)

Safety profile of inactivated COVID-19 vaccine in indonesian adults
by: Hindra Irawan Satari, et al.
Published: (2023-08-01)

ANTIBODY IgG LEVELS AND ADVERSE EVENTS FOLLOWING IMMUNIZATION AFTER THIRD DOSE OF MODERNA VACCINE IN HEALTHWORKERS AFTER TWO DOSES OF SINOVAC VACCINE
by: Ade Tiur Rumondang, et al.
Published: (2023-05-01)

Evaluation of the adverse events following immunization surveillance system in Guruve district, Mashonaland Central 2017
by: Mutata Constantine, et al.
Published: (2018-11-01)

A field based evaluation of adverse events following MenAfriVac, vaccine delivered in a controlled temperature chain (CTC) approach in Benin
by: Christoph Steffen, et al.
Published: (2014-08-01)

Investigation of Adverse Events Experienced by Healthcare Workers following Immunization with Homologous or Heterologous COVID-19 Booster Vaccinations
by: Yunhua Wei, et al.
Published: (2022-11-01)

Does This COVID-19 Pandemic Demand a Scale Up in AEFI Reporting in India?
by: Sadhvika Kanagat, et al.
Published: (2022-09-01)

A study to determine adverse event following immunization using COVISHIELD vaccine for prevention of COVID-19 infection in a field practice area of urban health center
by: Sarika P Patil, et al.
Published: (2022-06-01)

Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018–2020
by: Pasquale Stefanizzi, et al.
Published: (2022-01-01)

Hazards of vaccinating the way out of Covid-19 pandemic: Study of adverse events following immunization (Aefi) in India
by: Priti Nandkishor Tiwari, et al.
Published: (2022-01-01)

Intussusception and Other Adverse Event Surveillance after Pilot Introduction of Rotavirus Vaccine in Nam Dinh and Thua Thien Hue Provinces—Vietnam, 2017–2021
by: Ly Khanh Thi Le, et al.
Published: (2024-02-01)

Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021
by: Fuxing Chen, et al.
Published: (2022-12-01)

Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel
by: Rakhmad Hidayat, et al.
Published: (2022-05-01)

Incidence of early adverse events following covishield (ChAdOx1 nCoV-19) vaccination: A prospective study
by: Gajanan D Velhal, et al.
Published: (2022-01-01)

Farmacovigilancia hospitalaria
by: Ana Julia García Milián, et al.

Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
by: AbdulAzeez Adeyemi Anjorin, et al.
Published: (2022-04-01)

Vaccine-associated Arthus reaction
by: Tanatorn Soravipukuntorn, MD, et al.
Published: (2023-09-01)

Outcomes following COVID-19 vaccination and associated factors among healthcare professionals in Oromia region, Ethiopia
by: Dufera Rikitu Terefa, et al.
Published: (2023-01-01)

Vaccine adverse event reporting system (VAERS): Evaluation of 31 years of reports and pandemics’ impact
by: Ohoud A. Almadani, et al.
Published: (2022-12-01)

Effectiveness of coronavirus disease-19 vaccination on disease transmission, hospitalization, and clinical outcomes in adults in North India
by: Shah Kshitij Darshan
Published: (2021-01-01)

Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review
by: Francesco Sessa, et al.
Published: (2021-12-01)

Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China
by: Yu Hu, et al.
Published: (2022-01-01)

Safety of Monkeypox Vaccine Using Active Surveillance, Two-Center Observational Study in Italy
by: Marco Montalti, et al.
Published: (2023-06-01)

COVID-19 Vaccine Hesitancy: The Perils of Peddling Science by Social Media and the Lay Press
by: Shabeer Ali Thorakkattil, et al.
Published: (2022-06-01)

Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana
by: Peter Yamoah, et al.
Published: (2019-03-01)

Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases
by: Hossein Azarpanah, et al.
Published: (2021-09-01)